The Effect of Cognitive Impairment in the Elderly on the Initial and Long-Term Stability of Warfarin Therapy

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Unrecognized Psychosocial Factors Contributing to Bleeding Risk in Warfarin Therapy

(2011) Basia Diug et al.   STROKE

Warfarin maintenance dose in older patients: Higher average dose and wider dose frequency distribution in patients of African ancestry than those of European ancestry

(2010) Candice L. Garwood et al.   BLOOD CELLS MOLECULES AND DISEASES

Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation

(2010) Greg C. Flaker et al.  

Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)

(2010) A. J. ROSE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Two Different Models of Anticoagulation Management Services with Usual Medical Care

(2010) Kelly M Rudd et al.   PHARMACOTHERAPY

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy

(2009) D. M. Witt et al.   BLOOD

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.